Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alto, AN2, Argenx, Artelo, Ashvattha, Aurinia, Biogen, Celcuity, Chemomab, Corbus, Hansa, Idorsia, Inmune, InvIos, Moderna, OS.